385 related articles for article (PubMed ID: 21909879)
1. The role of annexin A2 in tumorigenesis and cancer progression.
Lokman NA; Ween MP; Oehler MK; Ricciardelli C
Cancer Microenviron; 2011 Aug; 4(2):199-208. PubMed ID: 21909879
[TBL] [Abstract][Full Text] [Related]
2. S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors.
Kwon M; MacLeod TJ; Zhang Y; Waisman DM
Front Biosci; 2005 Jan; 10():300-25. PubMed ID: 15574370
[TBL] [Abstract][Full Text] [Related]
3. The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target.
Sharma MC; Sharma M
Curr Pharm Des; 2007; 13(35):3568-75. PubMed ID: 18220793
[TBL] [Abstract][Full Text] [Related]
4. S100A10 and Cancer Hallmarks: Structure, Functions, and its Emerging Role in Ovarian Cancer.
Noye TM; Lokman NA; Oehler MK; Ricciardelli C
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30572596
[TBL] [Abstract][Full Text] [Related]
5. Phospholipid-associated annexin A2-S100A10 heterotetramer and its subunits: characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin.
MacLeod TJ; Kwon M; Filipenko NR; Waisman DM
J Biol Chem; 2003 Jul; 278(28):25577-84. PubMed ID: 12730231
[TBL] [Abstract][Full Text] [Related]
6. Annexin A2 (ANX A2): An emerging biomarker and potential therapeutic target for aggressive cancers.
Sharma MC
Int J Cancer; 2019 May; 144(9):2074-2081. PubMed ID: 30125343
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumour effects of all-trans retinoid acid on serous ovarian cancer.
Lokman NA; Ho R; Gunasegaran K; Bonner WM; Oehler MK; Ricciardelli C
J Exp Clin Cancer Res; 2019 Jan; 38(1):10. PubMed ID: 30621740
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression.
Sharma MR; Koltowski L; Ownbey RT; Tuszynski GP; Sharma MC
Exp Mol Pathol; 2006 Oct; 81(2):146-56. PubMed ID: 16643892
[TBL] [Abstract][Full Text] [Related]
9. Urokinase-type plasminogen activator stimulation of monocyte matrix metalloproteinase-1 production is mediated by plasmin-dependent signaling through annexin A2 and inhibited by inactive plasmin.
Zhang Y; Zhou ZH; Bugge TH; Wahl LM
J Immunol; 2007 Sep; 179(5):3297-304. PubMed ID: 17709546
[TBL] [Abstract][Full Text] [Related]
10. Annexin II: a plasminogen-plasminogen activator co-receptor.
Kim J; Hajjar KA
Front Biosci; 2002 Feb; 7():d341-8. PubMed ID: 11815288
[TBL] [Abstract][Full Text] [Related]
11. Annexin A2 and Kidney Diseases.
Lin L; Hu K
Front Cell Dev Biol; 2022; 10():974381. PubMed ID: 36120574
[TBL] [Abstract][Full Text] [Related]
12. Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro.
Díaz VM; Hurtado M; Thomson TM; Reventós J; Paciucci R
Gut; 2004 Jul; 53(7):993-1000. PubMed ID: 15194650
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen-stimulated inflammatory cytokine production by airway smooth muscle cells is regulated by annexin A2.
Schuliga M; Langenbach S; Xia YC; Qin C; Mok JS; Harris T; Mackay GA; Medcalf RL; Stewart AG
Am J Respir Cell Mol Biol; 2013 Nov; 49(5):751-8. PubMed ID: 23721211
[TBL] [Abstract][Full Text] [Related]
14. Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages.
Brownstein C; Deora AB; Jacovina AT; Weintraub R; Gertler M; Khan KM; Falcone DJ; Hajjar KA
Blood; 2004 Jan; 103(1):317-24. PubMed ID: 14504107
[TBL] [Abstract][Full Text] [Related]
15. Role of annexin II tetramer in plasminogen activation.
Kang HM; Choi KS; Kassam G; Fitzpatrick SL; Kwon M; Waisman DM
Trends Cardiovasc Med; 1999; 9(3-4):92-102. PubMed ID: 10578524
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation.
Sharma M; Ownbey RT; Sharma MC
Exp Mol Pathol; 2010 Apr; 88(2):278-86. PubMed ID: 20079732
[TBL] [Abstract][Full Text] [Related]
17. On the contribution of S100A10 and annexin A2 to plasminogen activation and oncogenesis: an enduring ambiguity.
Bydoun M; Waisman DM
Future Oncol; 2014 Dec; 10(15):2469-79. PubMed ID: 25525855
[TBL] [Abstract][Full Text] [Related]
18. EPAC1 regulates endothelial annexin A2 cell surface translocation and plasminogen activation.
Yang W; Mei FC; Cheng X
FASEB J; 2018 Apr; 32(4):2212-2222. PubMed ID: 29217666
[TBL] [Abstract][Full Text] [Related]
19. Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: possible biochemical mechanism of angiostatin's action.
Sharma MR; Rothman V; Tuszynski GP; Sharma MC
Exp Mol Pathol; 2006 Oct; 81(2):136-45. PubMed ID: 16643891
[TBL] [Abstract][Full Text] [Related]
20. Annexin A2 promotes glioma cell invasion and tumor progression.
Zhai H; Acharya S; Gravanis I; Mehmood S; Seidman RJ; Shroyer KR; Hajjar KA; Tsirka SE
J Neurosci; 2011 Oct; 31(40):14346-60. PubMed ID: 21976520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
